LLY News and Press, Eli Lilly and Company From 05/01/24

2024-05-01 06:01:13 ET Pfizer ( NYSE: PFE ) is reportedly developing a direct-to-consumer (DTC) platform to sell drugs directly to patients.... Read the full article on Seeking Alpha For further details see: Pfizer plans direct-to-consumer platform to sell Covid, mig...

2024-04-30 14:30:16 ET Image source: The Motley Fool. Eli Lilly (NYSE: LLY) Q1 2024 Earnings Call Apr 30, 2024 , 10:00 a.m. ET Operator Continue reading For further details see: Eli Lilly (LLY) Q1 2024 Earnings Call Transcript

2024-04-30 14:20:00 ET Summary The DEA will reportedly reclassify cannabis as a less dangerous drug, potentially moving it from Schedule I to Schedule III. Cannabis stocks surged after the news, with companies like Tilray, Canopy Growth, and Aurora Cannabis seeing a 20% increase. ...

2024-04-30 13:27:09 ET Eli Lilly and Company (LLY) Q1 2024 Earnings Conference Call April 30, 2024 10:00 AM ET Company Participants Joe Fletcher – Senior Vice President-Investor Relations Dave Ricks – Chief Executive Officer Anat Ashkenazi – ...

Eli Lilly and Company (NYSE: LLY) is one of today's top gainers. The company's shares have moved 4.8% on the day to $772.56. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Hum...

2024-04-30 10:57:26 ET The Eli Lilly And Company (NYSE: LLY) stock has jumped +53.33 (7.23%) after the company reported strong financial performance in its Q1 earnings report . At press time, the Eli Lilly stock was trading at $790.50 up from yesterday’s close of $737.17....

2024-04-30 09:18:00 ET U.S. stock index futures on Tuesday pointed to a lower open, with market participants receiving a deluge of earnings reports. Here are some stocks to watch on Tuesday: ... Read the full article on Seeking Alpha For further details see: 5 stock...

2024-04-30 07:31:21 ET More on Eli Lilly Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M ...

2024-04-30 07:03:41 ET More on Eli Lilly Eli Lilly And The Alzheimer's Dilemma (Rating Upgrade) Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M ...

LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...